CIK 0001703057 · Large accelerated filer
AbCellera Biologics Inc.
Sign in to watch- Ticker
- ABCL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 559-9005
- Business address
- 150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Open-market buy 10% owner bought 200,000 shares at $11.46 ($2,292,460)
- 4 Option exercise Chief Executive Officer acquired 56,125 shares (option exercise)
- EFFECT Other Notice of Effectiveness
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- UPLOAD Other SEC-generated Letter
- 10-K/A Report 10-K/A
- POS AM Other Post-effective Amendment for Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Executive or director change
- UPLOAD Other SEC-generated Letter
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure
- 8-K Event Shareholder vote results
- 4 Open-market buy 10% owner bought 64,088 shares at an average $8.03 ($514,908)
- 4 Open-market buy 10% owner bought 64,545 shares at $7.50 ($483,965)
- 4 Option exercise Chief Executive Officer acquired 56,125 shares (option exercise)
- 4 Open-market buy Chief Operating Officer bought 200,000 shares at $6.34 ($1,267,780)
- 4 Open-market buy 10% owner bought 300,000 shares at $7.26 ($2,176,530)
Page 9 of 17 · 325 filings